{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:29:18Z","timestamp":1790281758414,"version":"4.1.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007488","name":"Indian Institute of Technology Delhi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007488","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.drudis.2025.104546","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T10:10:11Z","timestamp":1763374211000},"page":"104546","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Regulators of system xc\u2212\u2013glutathione-glutathione peroxidase 4 antioxidant pathway: Recent advances and challenges in targeting ferroptosis for cancer treatment"],"prefix":"10.1016","volume":"30","author":[{"family":"Priyanka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manya","family":"Vatsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7399-8364","authenticated-orcid":false,"given":"Santanu","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2025.104546_b0005","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","article-title":"Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications","volume":"185","author":"Stockwell","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2025.104546_b0010","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.chembiol.2020.03.013","article-title":"The chemistry and biology of ferroptosis","volume":"27","author":"Stockwell","year":"2020","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.drudis.2025.104546_b0015","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2025.104546_b0020","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.cell.2017.11.048","article-title":"Selenium utilization by GPX4 is required to prevent hydroperoxide-induced ferroptosis","volume":"172","author":"Ingold","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2025.104546_b0025","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2025.104546_b0030","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","article-title":"FSP1 is a glutathione-independent ferroptosis suppressor","volume":"575","author":"Doll","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2025.104546_b0035","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","article-title":"DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer","volume":"593","author":"Mao","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2025.104546_b0040","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/s41589-020-0613-y","article-title":"Metabolic determinants of cancer cell sensitivity to canonical ferroptosis inducers","volume":"16","author":"Soula","year":"2020","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.drudis.2025.104546_b0045","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1016\/j.cell.2023.05.003","article-title":"Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones","volume":"186","author":"Liang","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2025.104546_b0050","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.drudis.2025.104546_b0055","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/s41392-023-01606-1","article-title":"Targeting ferroptosis opens new avenues for the development of novel therapeutics","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.drudis.2025.104546_b0060","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.trecan.2024.01.013","article-title":"Immunogenicity of ferroptosis in cancer: a matter of context?","volume":"10","author":"Catanzaro","year":"2024","journal-title":"Trends Cancer"},{"key":"10.1016\/j.drudis.2025.104546_b0065","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3390\/biomedicines10040891","article-title":"The selenoprotein glutathione peroxidase 4: from molecular mechanisms to novel therapeutic opportunities","volume":"10","author":"Weaver","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.drudis.2025.104546_b0070","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.chembiol.2025.04.002","article-title":"N-acetyl-l-cysteine averts ferroptosis by fostering glutathione peroxidase 4","volume":"32","author":"Zheng","year":"2025","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.drudis.2025.104546_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2017.07.010","article-title":"Glutathione peroxidase 4-catalyzed reduction of lipid hydroperoxides in membranes: the polar head of membrane phospholipids binds the enzyme and addresses the fatty acid hydroperoxide group toward the redox center","volume":"112","author":"Cozza","year":"2017","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.drudis.2025.104546_b0080","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1021\/acs.biochem.1c00492","article-title":"Electrostatic drivers of GPx4 interactions with membrane, lipids, and DNA","volume":"60","author":"Labrecque","year":"2021","journal-title":"Biochemistry"},{"key":"10.1016\/j.drudis.2025.104546_b0085","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1107\/S2059798320016125","article-title":"Crystal structures of the selenoprotein glutathione peroxidase 4 in its apo form and in complex with the covalently bound inhibitor ML162","volume":"77","author":"Moosmayer","year":"2021","journal-title":"Acta Crystallogr D Struct Biol"},{"key":"10.1016\/j.drudis.2025.104546_b0090","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41589-021-00915-2","article-title":"Characterization of a patient-derived variant of GPX4 for precision therapy","volume":"18","author":"Liu","year":"2022","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.drudis.2025.104546_b0095","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.901565","article-title":"Post-translational modification of GPX4 is a promising target for treating ferroptosis-related diseases","volume":"9","author":"Cui","year":"2022","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.drudis.2025.104546_b0100","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1111\/cas.13701","article-title":"Fumarate hydratase inactivation in hereditary leiomyomatosis and renal cell cancer is synthetic lethal with ferroptosis induction","volume":"109","author":"Kerins","year":"2018","journal-title":"Cancer Sci"},{"key":"10.1016\/j.drudis.2025.104546_b0105","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1021\/acs.jmedchem.2c01415","article-title":"Discovery of a potent chloroacetamide GPX4 inhibitor with bioavailability to enable target engagement in mice, a potential tool compound for inducing ferroptosis in vivo","volume":"66","author":"Randolph","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2025.104546_b0110","doi-asserted-by":"crossref","first-page":"13312","DOI":"10.1021\/acs.jmedchem.1c00569","article-title":"Discovery of a potent glutathione peroxidase 4 inhibitor as a selective ferroptosis inducer","volume":"64","author":"Xu","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2025.104546_b0115","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.bmcl.2011.09.047","article-title":"Development of small-molecule probes that selectively kill cells induced to express mutant RAS","volume":"22","author":"Weiwer","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.drudis.2025.104546_b0120","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1021\/acs.jmedchem.3c01890","article-title":"Design, synthesis, and biological evaluation for first GPX4 and CDK dual inhibitors","volume":"67","author":"Zhu","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2025.104546_b0125","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.chembiol.2022.11.003","article-title":"Small-molecule allosteric inhibitors of GPX4","volume":"29","author":"Liu","year":"2022","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.drudis.2025.104546_b0130","doi-asserted-by":"crossref","first-page":"10036","DOI":"10.1021\/acs.jmedchem.3c00967","article-title":"Discovery of novel potent covalent glutathione peroxidase 4 inhibitors as highly selective ferroptosis inducers for the treatment of triple-negative breast cancer","volume":"66","author":"Chen","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2025.104546_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118189","article-title":"Discovery of novel benzylaniline derivatives containing chloroacetamide as GPX4 inhibitors with potential efficacy in triple-negative breast cancer","volume":"300","author":"Ning","year":"2025","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.drudis.2025.104546_b0140","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1039\/D3CC06215E","article-title":"Diazepam-based covalent modifiers of GPX4 induce ferroptosis in liver cancer cells","volume":"60","author":"Yadav","year":"2024","journal-title":"Chem Commun (Camb)"},{"key":"10.1016\/j.drudis.2025.104546_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115829","article-title":"Discovery and optimization of indirubin derivatives as novel ferroptosis inducers for the treatment of colon cancer","volume":"261","author":"Zhu","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.drudis.2025.104546_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127538","article-title":"Structure-activity relationships of GPX4 inhibitor warheads","volume":"30","author":"Eaton","year":"2020","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.drudis.2025.104546_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108852","article-title":"Design, synthesis, and biological evaluation of pseudolaric acid B derivatives as ferroptosis inducers in colon cancer cells","volume":"164","author":"Zhang","year":"2025","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.drudis.2025.104546_b0160","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/s41589-020-0501-5","article-title":"Selective covalent targeting of GPX4 using masked nitrile-oxide electrophiles","volume":"16","author":"Eaton","year":"2020","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.drudis.2025.104546_b0165","doi-asserted-by":"crossref","first-page":"20407","DOI":"10.1021\/jacs.9b10769","article-title":"Diacylfuroxans are masked nitrile oxides that inhibit GPX4 covalently","volume":"141","author":"Eaton","year":"2019","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.drudis.2025.104546_b0170","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1021\/acs.jmedchem.3c01608","article-title":"Novel covalent probe selectively targeting glutathione peroxidase 4 in vivo: potential applications in pancreatic cancer therapy","volume":"67","author":"Tang","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2025.104546_b0175","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1021\/acs.jmedchem.4c02530","article-title":"Development of a highly selective ferroptosis inducer targeting GPX4 with 2-ethynylthiazole-4-carboxamide as electrophilic warhead","volume":"68","author":"Gu","year":"2025","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2025.104546_b0180","doi-asserted-by":"crossref","first-page":"10477","DOI":"10.1039\/D4SC02002B","article-title":"How does ferrocene correlate with ferroptosis? Multiple approaches to explore ferrocene-appended GPX4 inhibitors as anticancer agents","volume":"15","author":"Li","year":"2024","journal-title":"Chem Sci"},{"key":"10.1016\/j.drudis.2025.104546_b0185","doi-asserted-by":"crossref","first-page":"15828","DOI":"10.1021\/acs.jmedchem.5c00839","article-title":"Diversity-oriented synthesis toward the discovery of ferrocenophane-appended GPX4 inhibitors as potent ferroptosis inducers with drug likeness","volume":"68","author":"Wang","year":"2025","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2025.104546_b0190","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1039\/D2SC06171F","article-title":"A chiral fluorescent Ir(iii) complex that targets the GPX4 and ErbB pathways to induce cellular ferroptosis","volume":"14","author":"Zhao","year":"2023","journal-title":"Chem Sci"},{"key":"10.1016\/j.drudis.2025.104546_b0195","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bbrc.2016.11.035","article-title":"Discovery of GPX4 inhibitory peptides from random peptide T7 phage display and subsequent structural analysis","volume":"482","author":"Sakamoto","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.drudis.2025.104546_b0200","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1039\/D3CS00344B","article-title":"Targeted protein degradation directly engaging lysosomes or proteasomes","volume":"53","author":"Kim","year":"2024","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.drudis.2025.104546_b0205","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nchembio.2079","article-title":"Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis","volume":"12","author":"Shimada","year":"2016","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.drudis.2025.104546_b0210","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/s41419-021-04306-2","article-title":"Fin56-induced ferroptosis is supported by autophagy-mediated GPX4 degradation and functions synergistically with mTOR inhibition to kill bladder cancer cells","volume":"12","author":"Sun","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.drudis.2025.104546_b0215","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg3049","article-title":"Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic cancer","volume":"15","author":"Li","year":"2023","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.drudis.2025.104546_b0220","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1039\/D2CS00193D","article-title":"PROTACs: past, present and future","volume":"51","author":"Li","year":"2022","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.drudis.2025.104546_b0225","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202206277","article-title":"Intracellular delivery of glutathione peroxidase degrader induces ferroptosis in vivo","volume":"61","author":"Luo","year":"2022","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.drudis.2025.104546_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2023.117352","article-title":"Design and synthesis of proteolysis-targeting chimeras (PROTACs) as degraders of glutathione peroxidase 4","volume":"90","author":"Cai","year":"2023","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.drudis.2025.104546_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106461","article-title":"Ugi reaction-assisted assembly of covalent PROTACs against glutathione peroxidase 4","volume":"134","author":"Zhu","year":"2023","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.drudis.2025.104546_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115393","article-title":"Structure-activity relationship study of RSL3-based GPX4 degraders and its potential noncovalent optimization","volume":"255","author":"Zheng","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.drudis.2025.104546_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.115072","article-title":"Dual degradation mechanism of GPX4 degrader in induction of ferroptosis exerting anti-resistant tumor effect","volume":"247","author":"Wang","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.drudis.2025.104546_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116110","article-title":"A potent GPX4 degrader to induce ferroptosis in HT1080 cells","volume":"265","author":"Song","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.drudis.2025.104546_b0255","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1021\/acsmedchemlett.3c00571","article-title":"ZX703: a small-molecule degrader of GPX4 inducing ferroptosis in human cancer cells","volume":"15","author":"Hu","year":"2024","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.drudis.2025.104546_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115343","article-title":"Discovery of ML210-based glutathione peroxidase 4 (GPX4) degrader inducing ferroptosis of human cancer cells","volume":"254","author":"Wang","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.drudis.2025.104546_b0265","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.freeradbiomed.2009.04.015","article-title":"Singlet-oxygen-mediated amino acid and protein oxidation: formation of tryptophan peroxides and decomposition products","volume":"47","author":"Gracanin","year":"2009","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.drudis.2025.104546_b0270","doi-asserted-by":"crossref","first-page":"12176","DOI":"10.1021\/acs.jmedchem.2c00855","article-title":"PDTAC: targeted photodegradation of GPX4 triggers ferroptosis and potent antitumor immunity","volume":"65","author":"Liu","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2025.104546_b0275","doi-asserted-by":"crossref","first-page":"9095","DOI":"10.1039\/D3SC01597A","article-title":"A GPX4-targeted photosensitizer to reverse hypoxia-induced inhibition of ferroptosis for non-small cell lung cancer therapy","volume":"14","author":"Hu","year":"2023","journal-title":"Chem Sci"},{"key":"10.1016\/j.drudis.2025.104546_b0280","doi-asserted-by":"crossref","first-page":"21344","DOI":"10.1021\/acs.jmedchem.4c02273","article-title":"Development of novel silicon-based hydrophobic tags (SiHyT) for targeted proteins degradation","volume":"67","author":"Ma","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2025.104546_b0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107115","article-title":"Design, synthesis, and biological evaluation of hydrophobic-tagged glutathione peroxidase 4 (GPX4) degraders","volume":"144","author":"Li","year":"2024","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.drudis.2025.104546_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116719","article-title":"Design, synthesis, and biological evaluation of RSL3-based GPX4 degraders with hydrophobic tags","volume":"277","author":"Ning","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.drudis.2025.104546_b0295","first-page":"1650","article-title":"Insights into the novel function of system Xc\u2212 in regulated cell death","volume":"25","author":"Tu","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.drudis.2025.104546_b0300","first-page":"3106","article-title":"SLC7A11\/xCT in cancer: biological functions and therapeutic implications","volume":"10","author":"Lin","year":"2020","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.drudis.2025.104546_b0305","doi-asserted-by":"crossref","first-page":"7147","DOI":"10.1038\/s41467-021-27414-1","article-title":"Molecular basis for redox control by the human cystine\/glutamate antiporter system xc","volume":"12","author":"Parker","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2025.104546_b0310","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.neuropharm.2003.08.006","article-title":"Differentiation of substrate and non-substrate inhibitors of transport system xc\u2212: an obligate exchanger of L-glutamate and L-cystine","volume":"46","author":"Patel","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drudis.2025.104546_b0315","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.bmc.2009.11.001","article-title":"Isoxazole analogues bind the system xc\u2212 transporter: structure-activity relationship and pharmacophore model","volume":"18","author":"Patel","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.drudis.2025.104546_b0320","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.1016\/j.bmcl.2013.08.080","article-title":"Microwave accelerated synthesis of isoxazole hydrazide inhibitors of the system xc\u2212 transporter: initial homology model","volume":"23","author":"Matti","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.drudis.2025.104546_b0325","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.neuint.2013.11.012","article-title":"Novel di-aryl-substituted isoxazoles act as noncompetitive inhibitors of the system xc\u2212 cystine\/glutamate exchanger","volume":"73","author":"Newell","year":"2014","journal-title":"Neurochem Int"},{"key":"10.1016\/j.drudis.2025.104546_b0330","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1038\/sj.leu.2402238","article-title":"Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the xc\u2212 cystine transporter: a new action for an old drug","volume":"15","author":"Gout","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.drudis.2025.104546_b0335","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/med.21933","article-title":"Ferroptosis-modulating small molecules for targeting drug-resistant cancer: challenges and opportunities in manipulating redox signaling","volume":"43","author":"Koeberle","year":"2023","journal-title":"Med Res Rev"},{"key":"10.1016\/j.drudis.2025.104546_b0340","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/ddr.21557","article-title":"Novel analogs of sulfasalazine as system xc\u2212 antiporter inhibitors: insights from the molecular modeling studies","volume":"80","author":"Patel","year":"2019","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.drudis.2025.104546_b0345","doi-asserted-by":"crossref","first-page":"6184","DOI":"10.1016\/j.bmcl.2011.07.081","article-title":"Inhibition of xc\u2212 transporter-mediated cystine uptake by sulfasalazine analogs","volume":"21","author":"Shukla","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.drudis.2025.104546_b0350","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s11064-019-02901-6","article-title":"System xc\u2212 antiporter inhibitors: azo-linked amino-naphthyl-sulfonate analogues of sulfasalazine","volume":"45","author":"Nehser","year":"2020","journal-title":"Neurochem Res"},{"key":"10.1016\/j.drudis.2025.104546_b0355","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41422-022-00642-w","article-title":"The structure of erastin-bound xCT-4F2hc complex reveals molecular mechanisms underlying erastin-induced ferroptosis","volume":"32","author":"Yan","year":"2022","journal-title":"Cell Res"},{"key":"10.1016\/j.drudis.2025.104546_b0360","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1021\/acs.chemrestox.3c00347","article-title":"Chemoproteomic profiling of erastin-interacting proteins","volume":"37","author":"Li","year":"2024","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.drudis.2025.104546_b0365","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nature05859","article-title":"RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels","volume":"447","author":"Yagoda","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2025.104546_b0370","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.02523","article-title":"Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis","volume":"3","author":"Dixon","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.drudis.2025.104546_b0375","doi-asserted-by":"crossref","first-page":"4787","DOI":"10.1016\/j.bmcl.2015.07.018","article-title":"Incorporation of metabolically stable ketones into a small molecule probe to increase potency and water solubility","volume":"25","author":"Larraufie","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.drudis.2025.104546_b0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116758","article-title":"Remodeling of sorafenib as an orally bioavailable ferroptosis inducer for lung cancer by chemical modification of adenine-binding motif","volume":"176","author":"Kim","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.drudis.2025.104546_b0385","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1172\/JCI124049","article-title":"Suppression of the SLC7A11\/glutathione axis causes synthetic lethality in KRAS-mutant lung adenocarcinoma","volume":"130","author":"Hu","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.drudis.2025.104546_b0390","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.freeradbiomed.2007.10.031","article-title":"Mechanisms of BSO (L-buthionine-S,R-sulfoximine)-induced cytotoxic effects in neuroblastoma","volume":"44","author":"Marengo","year":"2008","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.drudis.2025.104546_b0395","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2147\/JPR.S125045","article-title":"Identification of capsazepine as a novel inhibitor of system xc\u2212 and cancer-induced bone pain","volume":"10","author":"Fazzari","year":"2017","journal-title":"J Pain Res"},{"key":"10.1016\/j.drudis.2025.104546_b0400","doi-asserted-by":"crossref","first-page":"5926","DOI":"10.1038\/s41598-019-42251-5","article-title":"Small-molecule ferroptotic agents with potential to selectively target cancer stem cells","volume":"9","author":"Taylor","year":"2019","journal-title":"Sci Rep"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644625002594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644625002594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:07:46Z","timestamp":1780920466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644625002594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":80,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1359644625002594"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2025.104546","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulators of system xc\u2212\u2013glutathione-glutathione peroxidase 4 antioxidant pathway: Recent advances and challenges in targeting ferroptosis for cancer treatment","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2025.104546","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104546"}}